Analysis of available sequencing data (http://www.cbioportal.org/public-portal/index.do) of patient samples with several types of cancers points to the presence of genomic alterations in BAP31 in subsets of patients with lymphoma (10.4%) and esophageal cancers (5.0%), in addition to patients with epithelial cancers (e.g., gastric, bladder and ovarian cancers). Here, BCAP31 is linked to lymphoma.